logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Expert Opinion on Emerging Drugs cover

Expert Opinion on Emerging Drugs

IF2.7
Papers44
Citations897
Journal Papers 40
Publication Date
delete
At the forefront of gene-based therapies in Dravet syndrome
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-07-08
delete0
deleteOAAI
deleteAntonella Riva; Sara Di Gioacchino; Greta Volpedo; Beatrice Risso; Antonella De Lillo; Federico Zara; Antonio Falace; Pasquale Striano
deleteShare
deleteSave
Sigma 1 receptor agonists: the new trend or an emerging therapeutic option?
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-06-29
delete0
deleteOAAI
deleteTangui Maurice
deleteShare
deleteSave
Obefazimod (ABX464) for moderate-to-severe Crohn’s disease: clinical development of a novel oral therapeutic approach
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-06-29
delete0
deleteOAAI
deleteSailish Honap; Axel Dignass; Vipul Jairath; Fernando Magro; Silvio Danese; Laurent Peyrin-Biroulet
deleteShare
deleteSave
Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer’s disease
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-06-22
delete0
PREAI
deleteMadia Lozupone; Vittorio Dibello; Rodolfo Sardone; Roberta Zupo; Fabio Castellana; Ilaria Bortone; Luisa Lampignano; Michela Di Matteo; Giuseppe Moramarco; Flora Dellegrazie; Antonio Daniele; Vincenzo Solfrizzi; Francesco Panza
deleteShare
deleteSave
Emerging treatment options for chronic obstructive pulmonary disease: a look into 2026 and beyond
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-06-22
delete0
PREAI
deleteCarolyn J. Wang; Clarus Leung; Don D. Sin
deleteShare
deleteSave
Acute management of adult MOG antibody–associated disease: therapeutic choices and clinical outcomes
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-06-18
delete0
deleteOAAI
deleteEdgar Carnero Contentti; Eoin P. Flanagan; Ethel Ciampi
deleteShare
deleteSave
Beyond triptans in menstrual migraine: the emerging role of CGRP-targeted therapies
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-06-16
delete0
deleteOAAI
deleteLanfranco Pellesi; Damiana Scuteri; Andrea Burgalassi; Alberto Chiarugi; Paolo Martelletti
deleteShare
deleteSave
Emerging small molecules for ulcerative colitis: clinical advancements and trial insights
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-06-07
delete0
PREAI
deleteCristina Lanzotti; Fabrizio Fanizzi; Ferdinando D’Amico; Alessandra Zilli; Federica Furfaro; Mariangela Allocca; Virginia Solitano; Clelia Cicerone; Sara Massironi; Tommaso Lorenzo Parigi; Laurent Peyrin-Biroulet; Silvio Danese
deleteShare
deleteSave
Emerging claudin-18.2 antagonists in the treatment of biliary tract cancer
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-06-05
delete0
PREAI
deleteDaniel Neureiter; Dino Bekric; Christian Mayr; Tobias Kiesslich; Matthias Ocker
deleteShare
deleteSave
Emerging pharmacotherapies in Gaucher disease
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-05-19
delete0
deleteOAAI
deleteGregory M. Pastores
deleteShare
deleteSave
Potassium channel agonists emerging as treatment options for focal epilepsy: are we breaking new ground?
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-05-19
delete0
PREAI
deleteCristiana Pelorosso; Simona Balestrini; Renzo Guerrini
deleteShare
deleteSave
Phase II and III trials in systemic sclerosis: from recent FDA approvals to emerging applications of cellular therapies
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-05-18
delete0
deleteOAAI
deleteAlain Lescoat; Eisha Naveed; Dinesh Khanna
deleteShare
deleteSave
Emerging microbiome-based therapies for atopic dermatitis: clinical insights and future development
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-05-06
delete0
deleteOAAI
deleteKingsley Osei-Karikari; Kyle Jones; Anna Erickson; Ian A. Myles
deleteShare
deleteSave
Injectable, oral, gene-based, and vaccine-driven PCSK9-targeted therapies: emerging clinical insights shaping the future of hypercholesterolemia management
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-04-29
delete0
deleteOAAI
deleteThusyanthy Parameswaran; Amanda J. Hooper; John R. Burnett
deleteShare
deleteSave
Gene therapy for wet AMD: a paradigm shift in the standard of care
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-04-06
delete0
PREAI
deleteSamuel Asanad; David S. Boyer
deleteShare
deleteSave
Exploring the latest emerging drugs for the treatment of sickle cell disease
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-03-01
delete0
PREAI
deleteCannas, Giovanna
deleteShare
deleteSave
Targeting the gut microbiota as a treatment for obesity and cancer cachexia
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-03-01
delete0
PREAI
deleteGiannakogeorgou, Anna; Van Den Ende, Tom; Verhaar, Barbara J. H.; De Clercq, Nicolien; Van Laarhoven, Hanneke W. M.; Nieuwdorp, Max
deleteShare
deleteSave
What can we expect from a combination of datopotamab deruxtecan, carboplatin, and pembrolizumab for brain metastases from non-small cell lung cancer?
deleteExpert Opinion on Emerging Drugs
IF2.7
delete2026-03-01
delete0
PREAI
deleteZ. Gelatti, Ana C.; William Jr, William N.
deleteShare
deleteSave
Emerging therapeutic strategies in immune thrombocytopenia: an expert evaluation of the evolving treatment landscape
deleteEXPERT OPINION ON EMERGING DRUGS
IF2.7
delete2025-11-01
delete0
PREAI
deleteCharbel, Nicole; Rizkallah, Joe; Fawaz, Hassan; El Khoury, Sacha; Hodroj, Mohammad Hassan; Taher, Ali
deleteShare
deleteSave
Medical glaucoma management: what's new on the horizon?
deleteEXPERT OPINION ON EMERGING DRUGS
IF2.7
delete2025-11-01
delete0
PREAI
deleteLee, Moon J.; Salimi, Ali; Razeghinejad, Reza
deleteShare
deleteSave